These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8765410)

  • 1. Antitumor activity of interleukin 12 in preclinical models.
    Brunda MJ; Luistro L; Rumennik L; Wright RB; Dvorozniak M; Aglione A; Wigginton JM; Wiltrout RH; Hendrzak JA; Palleroni AV
    Cancer Chemother Pharmacol; 1996; 38 Suppl():S16-21. PubMed ID: 8765410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor and antimetastatic effects of interleukin 12.
    Fujiwara H; Hamaoka T
    Cancer Chemother Pharmacol; 1996; 38 Suppl():S22-6. PubMed ID: 8765411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of interferon-gamma in mediating the antitumor efficacy of interleukin-12.
    Brunda MJ; Luistro L; Hendrzak JA; Fountoulakis M; Garotta G; Gately MK
    J Immunother Emphasis Tumor Immunol; 1995 Feb; 17(2):71-7. PubMed ID: 7647958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor and antimetastatic activity of interleukin 12 against murine tumors.
    Brunda MJ; Luistro L; Warrier RR; Wright RB; Hubbard BR; Murphy M; Wolf SF; Gately MK
    J Exp Med; 1993 Oct; 178(4):1223-30. PubMed ID: 8104230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo.
    Sayers TJ; Wiltrout TA; McCormick K; Husted C; Wiltrout RH
    Cancer Res; 1990 Sep; 50(17):5414-20. PubMed ID: 2117482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine models of cancer cytokine gene therapy using interleukin-12.
    Tahara H; Zitvogel L; Storkus WJ; Robbins PD; Lotze MT
    Ann N Y Acad Sci; 1996 Oct; 795():275-83. PubMed ID: 8958939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer.
    Tahara H; Lotze MT
    Gene Ther; 1995 Mar; 2(2):96-106. PubMed ID: 7719935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: Effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines.
    Indrová M; Bubeník J; Mikysková R; Mendoza L; Símová J; Bieblová J; Jandlová T; Jinoch P; Smahel M; Vonka V; Pajtasz-Piasecka E
    Int J Oncol; 2003 Mar; 22(3):691-5. PubMed ID: 12579325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production.
    Nastala CL; Edington HD; McKinney TG; Tahara H; Nalesnik MA; Brunda MJ; Gately MK; Wolf SF; Schreiber RD; Storkus WJ
    J Immunol; 1994 Aug; 153(4):1697-706. PubMed ID: 7913943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity.
    Guo J; Wang B; Zhang M; Chen T; Yu Y; Regulier E; Homann HE; Qin Z; Ju DW; Cao X
    Gene Ther; 2002 Jun; 9(12):793-803. PubMed ID: 12040461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression.
    Ogawa M; Yu WG; Umehara K; Iwasaki M; Wijesuriya R; Tsujimura T; Kubo T; Fujiwara H; Hamaoka T
    Cancer Res; 1998 Jun; 58(11):2426-32. PubMed ID: 9622084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha.
    Halin C; Gafner V; Villani ME; Borsi L; Berndt A; Kosmehl H; Zardi L; Neri D
    Cancer Res; 2003 Jun; 63(12):3202-10. PubMed ID: 12810649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of interleukin 12 with pulse interleukin 2 and the rapid and complete eradication of murine renal carcinoma.
    Wigginton JM; Komschlies KL; Back TC; Franco JL; Brunda MJ; Wiltrout RH
    J Natl Cancer Inst; 1996 Jan; 88(1):38-43. PubMed ID: 8847724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine gene therapy of mesothelioma. Immune and antitumor effects of transfected interleukin-12.
    Caminschi I; Venetsanakos E; Leong CC; Garlepp MJ; Robinson BW; Scott B
    Am J Respir Cell Mol Biol; 1999 Sep; 21(3):347-56. PubMed ID: 10460752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors.
    Zitvogel L; Robbins PD; Storkus WJ; Clarke MR; Maeurer MJ; Campbell RL; Davis CG; Tahara H; Schreiber RD; Lotze MT
    Eur J Immunol; 1996 Jun; 26(6):1335-41. PubMed ID: 8647214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The potential of interleukin-12 for use in cancer therapy].
    Gately MK; Brunda MJ
    Gan To Kagaku Ryoho; 1996 Jul; 23(8):961-71. PubMed ID: 8687231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of tumor growth and induction of long-term antitumor memory by interleukin 12 electro-gene therapy.
    Li S; Zhang X; Xia X
    J Natl Cancer Inst; 2002 May; 94(10):762-8. PubMed ID: 12011227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin directs the accumulation of interleukin-12 induced IFN gamma into tumors for enhancing STAT1 dependent antitumor effect.
    Zhu S; Waguespack M; Barker SA; Li S
    Clin Cancer Res; 2007 Jul; 13(14):4252-60. PubMed ID: 17634555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.